Skip to Content
Merck
  • Proteomic analysis reveals USP7 as a novel regulator of palmitic acid-induced hepatocellular carcinoma cell death.

Proteomic analysis reveals USP7 as a novel regulator of palmitic acid-induced hepatocellular carcinoma cell death.

Cell death & disease (2022-06-23)
Sandhini Saha, Rohit Verma, Chandan Kumar, Bhoj Kumar, Amit Kumar Dey, Milan Surjit, Sivaram V S Mylavarapu, Tushar Kanti Maiti
ABSTRACT

Nutrient surplus and consequent free fatty acid accumulation in the liver cause hepatosteatosis. The exposure of free fatty acids to cultured hepatocyte and hepatocellular carcinoma cell lines induces cellular stress, organelle adaptation, and subsequent cell death. Despite many studies, the mechanism associated with lipotoxicity and subsequent cell death still remains poorly understood. Here, we have used the proteomics approach to circumvent the mechanism for lipotoxicity using hepatocellular carcinoma cells as a model. Our quantitative proteomics data revealed that ectopic lipids accumulation in cells severely affects the ubiquitin-proteasomal system. The palmitic acid (PA) partially lowered the expression of deubiquitinating enzyme USP7 which subsequently destabilizes p53 and promotes mitotic entry of cells. Our global phosphoproteomics analysis also provides strong evidence of an altered cell cycle checkpoint proteins' expression that abrogates early G2/M checkpoints recovery with damaged DNA and induced mitotic catastrophe leading to hepatocyte death. We observe that palmitic acid prefers apoptosis-inducing factor (AIF) mediated cell death by depolarizing mitochondria and translocating AIF to the nucleus. In summary, the present study provides evidence of PA-induced hepatocellular death mediated by deubiquitinase USP7 downregulation and subsequent mitotic catastrophe.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
P5091, ≥98% (HPLC)
Sigma-Aldrich
Annexin V-FITC Apoptosis Detection Kit
Sigma-Aldrich
Bovine Serum Albumin, heat shock fraction, protease free, fatty acid free, essentially globulin free, pH 7, ≥98%
Sigma-Aldrich
Nocodazole, ≥99% (TLC), powder
Sigma-Aldrich
DUB Inhibitor VI, P22077, The DUB Inhibitor VI, P22077 controls the biological activity of DUB. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.
Sigma-Aldrich
Mitochondrial Membrane Potential Kit, sufficient for 500 fluorometric tests (microplate readers)
Sigma-Aldrich
MG-132, Ready Made Solution, ≥90% (HPLC)